These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1654033)

  • 1. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
    Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
    Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of mice and swine with a pseudorabies virus mutant lacking thymidine kinase activity.
    McFarland MD; Hill HT
    Can J Vet Res; 1987 Jul; 51(3):340-4. PubMed ID: 2820561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine.
    Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C
    Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
    Mikulska-Skupień E; Szweda W; Procajło Z
    Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of various vaccination procedures on shedding, latency, and reactivation of attenuated and virulent pseudorabies virus in swine.
    Mengeling WL; Lager KM; Volz DM; Brockmeier SL
    Am J Vet Res; 1992 Nov; 53(11):2164-73. PubMed ID: 1466515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent studies on Aujesky's dissease in pigs and cattle (author's transl)].
    de Leeuw PW; Tiessink JW
    Tijdschr Diergeneeskd; 1980 Sep; 105(17):689-94. PubMed ID: 6252655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.
    McGregor S; Easterday BC; Kaplan AS; Ben-Porat T
    Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
    Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
    Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of memory B-cell responses in serum and mucosal fluids of swine for protective immunity against pseudorabies virus.
    Kimman TG; Oei-Lie N; van Zaane D
    Am J Vet Res; 1992 Nov; 53(11):1992-8. PubMed ID: 1334639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine.
    Swenson SL; McMillen J; Hill HT
    J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.